Table 4.
Protein marker | Cognitively unimpaired | Alzheimer’s disease | ||||||
---|---|---|---|---|---|---|---|---|
Unadjusted model | Adjusted model | Unadjusted model | Adjusted model | |||||
β (SE) | p value | β (SE) | p value | β (SE) | p value | β (SE) | p value | |
Aβ40 | 6.89 (2.09) | 0.004 | 6.79(2.01) | 0.005 | 8.69 (3.65) | 0.041 | 9.79 (3.99) | 0.049 |
Aβ42 | 5.09(1.35) | 0.001 | 4.79 (1.33) | 0.002 | 6.53 (2.42) | 0.021 | 8.86 (2.70) | 0.011 |
F2-IP | − 0.03 (3.11) | 0.993 | 1.88 (3.48) | 0.594 | 1.46 (5.62) | 0.804 | 2.34 (10.89) | 0.844 |
Tau | − 3.58 (2.52) | 0.171 | − 2.74 (2.46) | 0.279 | − 5.13 (2.32) | 0.055 | − 5.67 (3.08) | 0.115 |
pTau-181 | − 0.21 (2.62) | 0.938 | − 0.06 (2.46) | 0.981 | 8.52 (2.6) | 0.007 | 9.05 (2.85) | 0.011 |
IFNg | − 0.74 (2.18) | 0.737 | 0.97 (2.18) | 0.661 | − 3.29 (3.75) | 0.409 | − 6.12 (4.84) | 0.246 |
TNFα | − 0.82 (1.81) | 0.653 | − 3.09 (1.65) | 0.075 | 6.98 (2.43) | 0.017 | 8.41 (2.96) | 0.025 |
RANTES | − 0.04 (1.98) | 0.983 | 0.85 (1.92) | 0.661 | 0.68 (4.61) | 0.885 | − 1.86 (8.17) | 0.826 |
MIP1α | − 0.13 (2.14) | 0.951 | 0.39 (2.07) | 0.853 | − 5.26 (4.11) | 0.230 | − 8.87 (6.04) | 0.185 |
MCP-1 | 0.89 (2.53) | 0.728 | 1.38 (2.54) | 0.593 | 0.03 (4.31) | 0.995 | 2.12 (8.43) | 0.809 |
IL-7 | − 2.89 (2.27) | 0.216 | − 4.80 (2.39) | 0.058 | − 0.57 (4.81) | 0.907 | − 3.29 (6.66) | 0.634 |
IL-6 | 3.69 (2.68) | 0.181 | 2.88 (2.92) | 0.334 | − 4.94 (3.73) | 0.212 | − 5.34 (4.88) | 0.306 |
IL-10 | 0.98 (1.87) | 0.605 | 2.72 (1.85) | 0.158 | − 6.75 (2.84) | 0.037 | − 8.10 (3.74) | 0.061 |
VEGF | − 1.85 (2.51) | 0.469 | − 2.01 (2.38) | 0.407 | 2.54 (4.07) | 0.546 | 1.54 (5.81) | 0.797 |
Multiple regression modeling was used to adjust for potential contributions of age, sex, and education years
β standardized β coefficient; SE standard error
Significant p values (< 0.05) are highlighted in bold